GlassScriptPhysician profile
Anesha Victor
NPI 1215346150
$3,259.41
in general payments reported to CMS, 2019-2025
19 companies · $946 in 2025
The $946 reported for 2025 was more than what 84% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $381 · 2022: $466 · 2023: $545 · 2024: $921 · 2025: $946.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,412.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,411.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $702.80 | 2021-2024 | Xarelto |
| Merck Sharp & Dohme LLC | $388.26 | 2022-2024 | Verquvo, Steglatro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $342.30 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $326.04 | 2024-2025 | Wegovy, Ozempic, Rybelsus |
| Pfizer INC. | $231.91 | 2022-2025 | |
| Abbott Laboratories | $198.43 | 2021-2025 | Ensite, Cardiomems, Merlin@Home |
| E.R. Squibb & Sons, L.L.C. | $171.70 | 2023-2025 | Camzyos, Eliquis |
| Bayer Healthcare Pharmaceuticals INC. | $162.59 | 2024-2025 | |
| Astrazeneca Pharmaceuticals LP | $151.78 | 2021-2025 | Brilinta, Farxiga |
| Medtronic, INC. | $127.08 | 2021-2025 | Micra |
| Novartis Pharmaceuticals Corporation | $126.07 | 2022-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $91.17 | 2022-2023 | Lifevest |
| Alnylam Pharmaceuticals INC. | $63.05 | 2025 | |
| Bridgebio Pharma, INC. | $52.37 | 2025 | Attruby |
| Amgen INC. | $37.50 | 2025 | Repatha |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mannkind Corporation | $26.18 | 2025 | |
| Philips North America LLC | $25.44 | 2025 | Ambulatory Monitoring & Diagnostics Undivided |
| Angiodynamics, INC. | $17.65 | 2025 | Auryon Laser System 100-120 Vac |
| Lilly USA, LLC | $17.09 | 2025 | Zepbound, Mounjaro |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anesha Victor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.